Job Recruitment Website - Job information - How about Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd.

How about Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd.

Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd. is another limited liability company registered in Beijing Economic and Technological Development Zone. Its registered address is 20 14- 10, and its registered address is Room 502- 1 5, Building 33, No.99 Kechuang 14th Street, Beijing Economic and Technological Development Zone.

The unified social credit code/registration number of Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd. is 910302318000895n, and the enterprise is in the opening state.

The business scope of Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd. is: medical research and experimental development; Technology transfer and technical services; Family labor service (excluding administrative licensing items); Corporate image planning and economic information consultation (excluding administrative licensing items); Conference services; Organizing cultural and artistic exchange activities (excluding performances); Sales of small gifts, daily necessities, a class of medical devices. (Enterprises independently choose business projects and carry out business activities according to law; Projects that must be approved according to law shall, after being approved by the relevant departments, carry out business activities in accordance with the approved contents; Shall not engage in business activities of projects prohibited and restricted by the industrial policies of this Municipality. )。 In Beijing, the total registered capital of companies with similar business scope is 302.332 billion yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, totaling 2,565. In the province, the registered capital of enterprises is good at present.

Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd. invested 1 company and 0 branches.

See more information and materials of Huang Tu Pharmaceutical R&D (Beijing) Co., Ltd. through Baidu Enterprise Credit.